FIELD: medicine.
SUBSTANCE: method involves studying lacrimal fluid chemoluminescence and macula light sensitivity in photostress test. Induced lacrimal fluid chemoluminescence values starting from 0.031-0.043 relative units and light sensitivity within 45 to 50 s limits, low clinical diabetic retinopathy manifestations risk is to predicted. Induced lacrimal fluid chemoluminescence values starting from 0.044-0.06 relative units and light sensitivity within 56 to 75 s limits, high clinical diabetic retinopathy manifestations risk is to predicted.
EFFECT: high accuracy of early stage prognosis.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DIABETIC RETINOPATHY ACCOMPANYING TYPE 2 DIABETES MELLITUS IN YAKUTS | 2011 |
|
RU2473091C1 |
| METHOD OF PREDICTING RISK OF DIABETIC RETINOPATHY DEVELOPMENT IN CASE OF TYPE 2 DIABETES MELLITUS IN YAKUTS | 2010 |
|
RU2430361C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DAIBETIC RETINOPATHY ACCOMPANYING TYPE 2 DIABETES MELLITUS IN YAKUT FEMALES | 2011 |
|
RU2461005C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DIABETIC RETINOPATHY ACCOMPANYING TYPE 2 DIABETES MELLITUS IN YAKUT MALES | 2011 |
|
RU2473092C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DAIBETIC RETINOPATHY ACCOMPANYING TYPE 2 DIABETES MELLITUS IN YAKUTS | 2011 |
|
RU2465598C1 |
| METHOD OF PREDICTING DIABETIC RETINOPATHY | 2009 |
|
RU2387362C1 |
| METHOD FOR PREDICTING A FAVORABLE MORPHOFUNCTIONAL RESPONSE TO ANTIANGIOGENIC THERAPY IN DIABETIC MACULAR EDEMA | 2022 |
|
RU2785861C1 |
| METHOD OF PREDICTING DIABETIC RETINOPATHY | 2009 |
|
RU2393754C1 |
| METHOD FOR EARLY DIAGNOSTICS AND PREDICTION OF DIABETIC AND HYPERTENSIVE RETINOPATHY PROGRESSING IN CASE OF COMBINED COURSE OF TYPE 2 DIABETES MELLITUS AND HYPERTENSIVE DISEASE | 2015 |
|
RU2610535C1 |
| METHOD FOR FORECASTING DEGREE OF RISK OF DIABETES MACULAR EDEMA DEVELOPMENT IN PATIENTS WITH TYPE II SUGAR DIABETES | 2007 |
|
RU2334469C1 |
